FDA says FDC Nutrition's Inositol 100% Pure Free Form is an unapproved new drug and misbranded because website claims treat diseases.
What happened
In December 2020, FDA reviewed www.fdcnutrition.com and found the company takes orders there for Inositol 100% Pure Free Form. FDA said label and website claims—such as reducing anxiety by affecting serotonin, aiding blood sugar control, improving fertility in women with PCOS, and reducing depression symptoms—show the product is intended to treat disease. FDA cited the product as an unapproved new drug and misbranded for lacking adequate directions for use.
What FDA found
Website and label claims that the product reduces anxiety, aids blood sugar control, improves fertility in women with PCOS, and reduces depression symptoms make it a drug intended to treat disease.
section 201(g)(1)(B) of the Act [21 U.S.C. § 321(g)(1)(B)]The product is a new drug—not generally recognized as safe and effective for those uses and without FDA approval.
section 201(p) of the Act [21 U.S.C. § 321(p)]; sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]The product is misbranded because it lacks adequate directions for use.
section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)]; 21 C.F.R. § 201.5Selling or shipping this misbranded drug in interstate commerce violates the Act.
section 301(a) of the Act [21 U.S.C. § 331(a)]
What FDA wants
FDA asks FDC Nutrition to notify FDA in writing within 15 working days of receipt, by email to FDAAdvisory@fda.hhs.gov, of steps taken to correct the violations and prevent recurrence, with supporting documents. If it cannot finish in that time, it must state why and when it will.
Who should pay attention
- supplement brands that make disease-treatment claims
- retailers and online marketplaces selling inositol products
- companies marketing products for anxiety, PCOS, depression, or blood sugar
This is a summary. Read the original letter on fda.gov.